FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Sacrosidase (Sucraid) Oral Solution
Status: Currently in Shortage
»Date first posted: 07/09/2015
»Therapeutic Categories: Gastroenterology; Inborn Errors

QOL Medical, LLC (Revised 10/24/2018)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
8,500 I.U./mL 118 mL per bottle, 2 bottles/box (NDC 67871-111-04) Available

Sucraid Lot D1015 Physician and Patient Informed Consent Forms to Obtain Product

Link to FDA Related Information for Sacrosidase Oral Solution
*Important Update: Expiration Date for Sucraid Lot B1210
Requirements related to complying with good manufacturing practices.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English